Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma

The primary objective is to determine the safety and efficacy of belzupacap sarotalocan (bel-sar) compared to sham control in patients with primary indetermina…

Choroidal MelanomaIndeterminate LesionsUveal Melanoma+1 more

Estimated

~$10 – $8,750

Aura BiosciencesNCT06007690